Document Detail


Early risk factors for pregnancy loss in lupus.
MedLine Citation:
PMID:  16449114     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To identify early risk factors for pregnancy loss in lupus pregnancies. METHODS: We conducted a cohort study of all pregnancies seen in the first trimester in lupus patients followed from 1987 to 2002 at the Hopkins Lupus Center. At each visit, vital signs, a complete blood count, a urinalysis, and a 24-hour urine collection for total protein, if the dipstick revealed proteinuria, were obtained. Proteinuria was defined as protein greater than 500 mg in a 24-hour urine collection. Secondary antiphospholipid syndrome was diagnosed by using the Sapporo criteria. Thrombocytopenia was defined as platelets under 150,000. Hypertension was defined as blood pressure over 140/90 mm Hg during the first trimester. Pregnancies electively terminated were excluded from this study. RESULTS: One hundred sixty-six pregnancies in 125 women were followed in the Hopkins Lupus Cohort from the first trimester onward. Twenty-seven pregnancies (16%) ended with a loss. Pregnancy loss was increased 2.6 times in women with first-trimester proteinuria (P = .04). A diagnosis of secondary antiphospholipid syndrome led to a 3.1-fold increase in pregnancy loss, predominantly after 20 weeks of gestation (P = .004). Thrombocytopenia in the first trimester led to an increase in pregnancy loss by 3.3 fold (P < or = .001). First-trimester hypertension led to a 2.4-fold increase in pregnancy loss (P = .027). Each risk factor was independent in raising pregnancy loss risk. CONCLUSION: The acronym PATH can help remind clinicians to monitor for Proteinuria, Antiphospholipid syndrome, Thrombocytopenia, and Hypertension early in pregnancy. Close observation, with frequent laboratory analysis and appropriate therapy, is important to pregnancy success in women with lupus. LEVEL OF EVIDENCE: II-2.
Authors:
Megan E B Clowse; Laurence S Magder; Frank Witter; Michelle Petri
Related Documents :
2715994 - Fetal distress associated with the anticardiolipin antibody and a history of intrauteri...
2109614 - Characteristics of high-titer igg antiphospholipid antibody in systemic lupus erythemat...
6496544 - Lupus pregnancy. case-control prospective study demonstrating absence of lupus exacerba...
10701844 - Serum inhibin a levels in pregnant women with systemic lupus erythematosus or antiphosp...
24646294 - Cervical length in asymptomatic twin pregnancies: prospective multicenter comparison of...
22149474 - Neural tube defects in wales: changing demographics from 1998 to 2009.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  107     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-02-01     Completed Date:  2006-04-04     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  293-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Division of Rheumatology, Duke University Medical Center, Durham, NC 27110, USA. meganclowse@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Spontaneous / epidemiology*,  etiology*
Adult
Female
Humans
Lupus Erythematosus, Systemic / complications*
Pregnancy
Pregnancy Trimester, First
Risk Factors
Grant Support
ID/Acronym/Agency:
M01RR00052/RR/NCRR NIH HHS; R01 AR43737/AR/NIAMS NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Outcomes of pregnancies complicated by hyperemesis gravidarum.
Next Document:  Association between low day 16 hCG and miscarriage after proven cardiac activity.